07th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200046672 | SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID | 2020-02-13 |
20200046673 | Method of treating patients with a factor Xa inhibitor, Aspirin, and Verapamil | 2020-02-13 |
20200046674 | AMINOCARBONYLCARBAMATE COMPOUNDS | 2020-02-13 |
20200046675 | Cannabinoid Formulation Packaged in a Glass Vial For Pulmonary Delivery | 2020-02-13 |
20200046676 | THERAPEUTIC AGENT FOR NEUROPATHY IN ORGANIC ACIDEMIA OF WHICH MECHANISM RELIES ON INCREASE IN CAMP | 2020-02-13 |
20200046678 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR INHIBITING BACTERIAL GROWTH | 2020-02-13 |
20200046679 | DIHYDROARTEMISININ-STEROID CONJUGATE AND PREPARATION METHOD AND APPLICATION THEREOF | 2020-02-13 |
20200046680 | SMALL ORGANIC MOLECULES FOR USE IN THE TREATMENT OF NEUROINFLAMMATORY DISORDERS | 2020-02-13 |
20200046681 | ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION | 2020-02-13 |
20200046682 | CYCLIC NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF | 2020-02-13 |
20200046683 | METHOD OF TREATMENT FOR KETAMINE INFUSION | 2020-02-13 |
20200046684 | ANTICANCER COMBINATION THERAPY | 2020-02-13 |
20200046685 | COMBINATION THERAPY | 2020-02-13 |
20200046686 | MEDICAMENT CONTAINING PEMAFIBRATE | 2020-02-13 |
20200046687 | METHODS AND COMPOSITIONS FOR TREATING PAIN | 2020-02-13 |
20200046688 | PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN | 2020-02-13 |
20200046689 | PIM KINASE INHIBITORS IN COMBINATION WITH RNA SPLICING MODULATORS/INHIBITORS FOR TREATMENT OF CANCERS | 2020-02-13 |
20200046690 | METHODS AND COMPOSITIONS FOR INHIBITION OF EGF/EGFR PATHWAY IN COMBINATION WITH ANAPLASTIC LYMPHOMA KINASE INHIBITORS | 2020-02-13 |
20200046691 | ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS | 2020-02-13 |
20200046692 | SPECIFIC AKT3 INHIBITOR AND USES THEREOF | 2020-02-13 |
20200046693 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ZELLWEGER SPECTRUM DISORDER | 2020-02-13 |
20200046694 | LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS | 2020-02-13 |
20200046695 | ORAL PHARMACEUTICAL COMPOSITION OF LURASIDONE AND PREPARATION THEREOF | 2020-02-13 |
20200046696 | TREATMENT OF CANCER WITH SMG1-INHIBITORS | 2020-02-13 |
20200046697 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | 2020-02-13 |
20200046698 | PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND AN AURORA KINASE INHIBITOR AND METHODS OF USE THEREOF | 2020-02-13 |
20200046699 | COMPOSITIONS AND METHODS FOR INHIBITING KINASES | 2020-02-13 |
20200046700 | FOCAL ADHESION KINASE INHIBITOR AS A THERAPEUTIC AGENT IN DIABETES | 2020-02-13 |
20200046701 | Combination Therapy for Use in Treating Retroviral Infections | 2020-02-13 |
20200046702 | TREATMENT OF INFLAMMATORY CONDITIONS AND AUTOIMMUNE DISEASES WITH GLUCOSE UPTAKE INHIBITORS | 2020-02-13 |
20200046703 | COMPOSITIONS AND METHODS FOR TREATMENT OF THE SIDE-EFFECTS ASSOCIATED WITH ADMINISTRATION OF THERAPEUTIC AGENTS | 2020-02-13 |
20200046704 | SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION | 2020-02-13 |
20200046705 | METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | 2020-02-13 |
20200046706 | Composition for Inducing Differentiation and Protection of Neural Stem Cells and Method for Inducing Neuro-Regeneration Using the Same Composition | 2020-02-13 |
20200046707 | TOPICAL FORMULATION FOR A JAK INHIBITOR | 2020-02-13 |
20200046708 | TRAMETINIB PREVENTS MESOTHELIAL-MESENCHYMAL TRANSITION AND AMELIORATES ABDOMINAL ADHESION AND PULMONARY FIBROSIS FORMATION | 2020-02-13 |
20200046709 | PYRIMIDINE COMPOUNDS AS JAK KINASE INHIBITORS | 2020-02-13 |
20200046710 | SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS | 2020-02-13 |
20200046711 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NONALCOHOLIC STEATOHEPATITIS, HEPATIC FIBROSIS, AND LIVER CIRRHOSIS, COMPRISING ADENOSINE DERIVATIVES | 2020-02-13 |
20200046712 | PROCESS FOR MAKING 1,3,7- TRIMETHYLURIC ACID WATER SOLUBLE SALTS OR CO-CRYSTALS AND THEIR USAGE IN DIETARY SUPPLEMENTS OR FUNCTIONAL FOODS FORMULATIONS | 2020-02-13 |
20200046713 | TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN | 2020-02-13 |
20200046714 | Treating Male Senescence | 2020-02-13 |
20200046715 | Medicament for Treating Peripheral Neuropathies | 2020-02-13 |
20200046716 | LAMOTRIGINE SUSPENSION DOSAGE FORM | 2020-02-13 |
20200046717 | USE OF A PPAR-DELTA AGONIST FOR REDUCING LOSS OF MUSCLE STRENGTH, MUSCLE MASS, OR TYPE I MUSCLE FIBERS IN AN IMMOBILIZED LIMB | 2020-02-13 |
20200046718 | THERAMUTEIN MODULATORS | 2020-02-13 |
20200046719 | FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND | 2020-02-13 |
20200046721 | PAR-4 AGONISTS FOR THE TREATMENT OF CANCER | 2020-02-13 |
20200046722 | METHOD AND COMPOSITION FOR TREATING EATING DISORDERS | 2020-02-13 |
20200046723 | Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity | 2020-02-13 |
20200046724 | BETA-LACTAMASE INHIBITORS AND USES THEREOF | 2020-02-13 |
20200046725 | Prodrug Comprising a Drug Linker Conjugate | 2020-02-13 |
20200046726 | USE OF CDK9 AND BRD4 INHIBITORS TO INHIBIT INFLAMMATION | 2020-02-13 |
20200046727 | TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH | 2020-02-13 |
20200046728 | COMPOSITION COMPRISING OLEANOLIC ACID ACETATE AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING RENAL TOXICITY INDUCED BY MEDICINE | 2020-02-13 |
20200046729 | METHODS USING COMBINED ORAL CONTRACEPTIVE COMPOSITIONS WITH REDUCED CARDIOVASCULAR EFFECTS | 2020-02-13 |
20200046730 | Human papilloma virus replication inhibitors | 2020-02-13 |
20200046731 | BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS | 2020-02-13 |
20200046732 | ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME | 2020-02-13 |
20200046733 | PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME | 2020-02-13 |
20200046734 | Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk | 2020-02-13 |
20200046735 | COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE | 2020-02-13 |
20200046736 | COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE | 2020-02-13 |
20200046737 | METHODS FOR TREATING CANCER, AND COMPOSITIONS THEREFOR | 2020-02-13 |
20200046738 | FATTY ACID ACETYLATED SALICYLATES AND THEIR USES | 2020-02-13 |
20200046739 | PHARMACEUTICAL TETRACYCLINE COMPOSITION FOR DERMATOLOGICAL USE | 2020-02-13 |
20200046740 | TARGETING HYPOXIC CANCER STEM CELLS (CSCS) WITH DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY | 2020-02-13 |
20200046741 | SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME | 2020-02-13 |
20200046742 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | 2020-02-13 |
20200046743 | SALTS OF PRODRUGS OF PIPERAZINE AND SUBSTITUTED PIPERIDINE ANTIVIRAL AGENTS | 2020-02-13 |
20200046744 | Phospholipid Compositions | 2020-02-13 |
20200046745 | BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2020-02-13 |
20200046746 | ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME | 2020-02-13 |
20200046747 | SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS | 2020-02-13 |
20200046748 | USE OF ALBIFLORIN IN PREPARATION OF PRODUCTS FOR IMPROVING FUNCTION OF INTESTINAL FLORA SYSTEM | 2020-02-13 |
20200046749 | COMBINATIONS TO TREAT CANCER | 2020-02-13 |
20200046750 | USE OF cADPR OR NAADP ANTAGONISTS | 2020-02-13 |
20200046751 | COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | 2020-02-13 |
20200046752 | CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES | 2020-02-13 |
20200046753 | Modified pT7/T7 Polymerase System for Sustained shRNA Expression in Cytoplasm and Liposome Transporter Comprising the Same | 2020-02-13 |
20200046754 | WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS | 2020-02-13 |
20200046755 | POLYMER HYDROGELS AND METHODS OF PREPARATION THEREOF | 2020-02-13 |
20200046756 | POLYMER LUNG SURFACTANTS | 2020-02-13 |
20200046757 | CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE FORMULATIONS, AND USES THEREOF | 2020-02-13 |
20200046758 | ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF | 2020-02-13 |
20200046759 | THERAPEUTIC COMPOSITION AND METHODS | 2020-02-13 |
20200046760 | ANTIMICROBIAL POLY(ALKYLATED IMIDAZOLIUM) SALTS | 2020-02-13 |
20200046761 | PLANT BASED COMPOSITIONS AND METHODS FOR THE DELIVERY OF MAGNESIUM | 2020-02-13 |
20200046762 | SMECTITE SUSPENSION LIQUID COMPOSITION AND METHOD FOR PREPARING SAME | 2020-02-13 |
20200046763 | APPLICATION OF GSK3 INHIBITOR IN PREPARING A DRUG TO TREAT NIEMANN-PICK DISEASE TYPE C | 2020-02-13 |
20200046764 | PREPARATION OF HIGH-PREFERMANCE ANTIMICROBIAL AGENT BASED ON ZnO/GQD-PEI NANOCOMPOSITES | 2020-02-13 |
20200046765 | TOPICAL ANTIBIOTIC FORMULATIONS | 2020-02-13 |
20200046766 | CANCER STEM CELL EXOSOMES | 2020-02-13 |
20200046767 | METHOD FOR GENERATING T CELLS PROGENITORS | 2020-02-13 |
20200046768 | DOUBLE NEGATIVE T CELLS AND PD-1 BLOCKADE FOR THE TREATMENT OF CANCER | 2020-02-13 |
20200046769 | DUAL FUNCTION ENGINEERED T CELLS WITH HPV E6 SPECIFICITY AND PD-1 BLOCKADE | 2020-02-13 |
20200046770 | ACTIVATION OF NATURAL CYOTOXICITY RECEPTOR 2 (NCR2) | 2020-02-13 |
20200046771 | CRYOPRESERVED PLATELET COMPOSITIONS AND METHODS FOR MAKING | 2020-02-13 |
20200046772 | CARTILAGE REGENERATION-PROMOTING AGENT | 2020-02-13 |
20200046773 | Compositions and Method for Treating Primary Sclerosing Cholangitis and Related Disorders | 2020-02-13 |